Fabrizio Fabrizi

Summary

Affiliation: Ospedale Maggiore
Country: Italy

Publications

  1. doi request reprint Hepatitis B virus infection and the dialysis patient
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Semin Dial 21:440-6. 2008
  2. ncbi request reprint Lamivudine treatment for hepatitis B in dialysis population : case reports and literature review
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano
    Acta Gastroenterol Belg 76:423-8. 2013
  3. doi request reprint Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    J Med Virol 85:1019-27. 2013
  4. doi request reprint Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Policlinico Hospital, IRCCS Foundation, Milano, Italy
    Am J Kidney Dis 61:623-37. 2013
  5. doi request reprint The evidence-based epidemiology of HCV-associated kidney disease
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 35:621-8. 2012
  6. doi request reprint Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 15:600-6. 2008
  7. doi request reprint Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Pad Croff, Via Commenda 15, 20122 Milan, Italy
    Dig Dis Sci 57:1366-72. 2012
  8. pmc Hepatitis C virus infection and kidney disease: a meta-analysis
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Policlinico Hospital, IRCCS Foundation, Milan, Italy
    Clin J Am Soc Nephrol 7:549-57. 2012
  9. doi request reprint Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 18:871-6. 2011
  10. ncbi request reprint A new single-dose hepatitis B vaccine versus a conventional vaccine in patients with end-stage renal disease
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, Policlinico IRCCS, Milan, Italy
    Nat Clin Pract Nephrol 2:356-7. 2006

Detail Information

Publications100

  1. doi request reprint Hepatitis B virus infection and the dialysis patient
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Semin Dial 21:440-6. 2008
    ..No rigorously controlled treatment trials for treatment of hepatitis B with either interferon or lamivudine therapy in dialysis patients are currently available...
  2. ncbi request reprint Lamivudine treatment for hepatitis B in dialysis population : case reports and literature review
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano
    Acta Gastroenterol Belg 76:423-8. 2013
    ..Clinical trials are in progress to assess efficacy and safety of last-generation nucleos(t)ide analogues for anti-HBV therapy in dialysis population...
  3. doi request reprint Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    J Med Virol 85:1019-27. 2013
    ..HCV-related mixed cryoglobulinemia is uncommon in developed countries and this clearly hampers randomized controlled clinical trials aimed to evaluate efficacy and safety of antiviral therapy in non-immunosuppressed individuals...
  4. doi request reprint Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Policlinico Hospital, IRCCS Foundation, Milano, Italy
    Am J Kidney Dis 61:623-37. 2013
    ..Of note, rituximab, a chimeric monoclonal antibody that blocks CD20 receptors on B cells, has been reported to be effective for the treatment of mixed cryoglobulinemia symptoms, including glomerulonephritis...
  5. doi request reprint The evidence-based epidemiology of HCV-associated kidney disease
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 35:621-8. 2012
    ..Prospective studies are needed to fully characterize the exact impact of chronic HCV infection on kidney function trajectories over time...
  6. doi request reprint Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 15:600-6. 2008
    ..No difference in the drop-out rate between study and control patients occurred in the subgroup of dialysis patients on IFN monotherapy. These results support IFN-based therapy for hepatitis C in patients on maintenance dialysis...
  7. doi request reprint Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Pad Croff, Via Commenda 15, 20122 Milan, Italy
    Dig Dis Sci 57:1366-72. 2012
    ..Patients with chronic kidney disease frequently have a compromised nutritional status; however, the impact of malnutrition on the immune response to hepatitis B virus vaccine in chronic kidney disease patients remains unclear...
  8. pmc Hepatitis C virus infection and kidney disease: a meta-analysis
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Policlinico Hospital, IRCCS Foundation, Milan, Italy
    Clin J Am Soc Nephrol 7:549-57. 2012
    ..Hepatitis C virus (HCV) infection and kidney disease are both highly prevalent diseases. The association between HCV and GN has been supported by previous research but little is known about the relationship between HCV and kidney disease...
  9. doi request reprint Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 18:871-6. 2011
    ..These results support the use of recombinant vaccine against hepatitis B in patients on regular dialysis with HCV infection...
  10. ncbi request reprint A new single-dose hepatitis B vaccine versus a conventional vaccine in patients with end-stage renal disease
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, Policlinico IRCCS, Milan, Italy
    Nat Clin Pract Nephrol 2:356-7. 2006
  11. ncbi request reprint Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Aliment Pharmacol Ther 24:789-96. 2006
    ..Several authors suggested a benefit for granulocyte macrophage-colony stimulating factor (GM-CSF) as an adjuvant to HBV vaccination in patients with end-stage renal disease (ESRD). However, consistent information is still lacking...
  12. ncbi request reprint Meta-analysis: terlipressin therapy for the hepatorenal syndrome
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Aliment Pharmacol Ther 24:935-44. 2006
    ..Recent reports have shown the efficacy of terlipressin therapy, a vasopressin analogue, in hepatorenal syndrome patients...
  13. ncbi request reprint Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS, Milan, Italy
    Aliment Pharmacol Ther 24:1413-22. 2006
    ..The efficacy and safety of interferon-based therapy in renal transplant recipients with hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue...
  14. ncbi request reprint Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Via Commenda 15, 20122 Milan, Italy
    Int J Artif Organs 30:212-9. 2007
    ..Although this suggests a role for an antiviral approach to HCV-associated GN instead of the more conventional immunosuppressive (or supportive) therapy, the optimal management of HCV related glomerulonephritis remains controversial...
  15. ncbi request reprint Lamivudine in the treatment of HBV-related liver disease after renal transplantation: an update
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Int J Artif Organs 28:211-21. 2005
    ..Also, the management of lamivudine resistance remains a concern for physicians. Clinical trials are under way...
  16. ncbi request reprint Hepatitis C virus infection and rituximab therapy after renal transplantation
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Int J Artif Organs 30:445-9. 2007
    ..Rituximab, a chimeric monoclonal antibody, has been successfully given in various diseases including HCV-associated mixed cryoglobulinemia. However, only preliminary data exists on its efficacy and safety after renal transplantation...
  17. ncbi request reprint Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS, Milan, Italy
    Aliment Pharmacol Ther 24:781-8. 2006
    ..A causal association between hepatitis B virus infection and the development of glomerulonephritis remains controversial. Also, the optimal therapy is undefined although several approaches have been made...
  18. ncbi request reprint Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Aliment Pharmacol Ther 24:497-506. 2006
    ..Dialysis patients have suboptimal response towards hepatitis B virus (HBV) vaccine and intradermal hepatitis B virus vaccination has been used to improve the response rate; however, its efficacy remains unclear...
  19. ncbi request reprint Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Transplant 5:1452-61. 2005
    ..This meta-analysis demonstrates that RT recipients with anti-HCV antibody have an increased risk of mortality and graft failure compared with HCV antibody negative patients...
  20. ncbi request reprint Treatment of hepatitis C in potential kidney and heart transplant patients
    Fabrizio Fabrizi
    Division of Liver Diseases, Mount Sinai Medical Center and School of Medicine, One Gustave L Levy Place, 1190 Fifth Ave, New York, NY 10029, USA
    Clin Liver Dis 9:487-503, viii. 2005
    ..This article reviews the literature concerning the treatment of HCV-related liver disease in renal and orthotopic heart transplantation...
  21. ncbi request reprint Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Transplant 5:2433-40. 2005
    ..This relationship provides one potential explanation for the adverse effects of HCV on patient and graft survival after RT...
  22. doi request reprint Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 18:e263-9. 2011
    ....
  23. ncbi request reprint HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Transplant 5:2913-21. 2005
    ..44 with a 95% CI of 1.02-2.04 (homogeneity test, p <0.0001). This meta-analysis shows that HBsAg positive RT recipients have an increased risk for mortality and graft failure compared to seronegative patients...
  24. ncbi request reprint Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Aliment Pharmacol Ther 23:1105-12. 2006
    ..Some authors have claimed that dialysis mode has an impact on the immune response to hepatitis B virus vaccine but consistent information is lacking on this issue...
  25. ncbi request reprint Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Aliment Pharmacol Ther 23:1559-66. 2006
    ..Several authors have reported on the benefit of thymopentin (TP5) as adjuvant to vaccine against hepatitis B virus in patients receiving regular dialysis. However, consistent information on this issue is still lacking...
  26. ncbi request reprint Hepatitis C virus infection and diabetes mellitus in end-stage renal disease: evidence of a negative association
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy, and Division of Liver Diseases, Mount Sinai Medical School, New York City, New York, USA
    Int J Artif Organs 29:691-7. 2006
    ..0006), and longer time on dialysis (P=0.00001). In summary, no link between anti-HCV antibody and DM occurred in this ESRD population; there was no association between rate of anti-HCV antibody and diabetic nephropathy...
  27. ncbi request reprint The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    J Viral Hepat 14:697-703. 2007
    ..The excess risk of death in HCV-positive patients may be at least partially attributed to chronic liver disease with its attendant complications...
  28. ncbi request reprint Hepatitis C virus infection and the dialysis patient
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS, Milan, Italy
    Semin Dial 20:416-22. 2007
    ..Successful pretransplant therapy is associated with several benefits after RT including reduced incidence of posttransplant diabetes mellitus and de novo glomerulonephritis in HCV-infected recipients...
  29. doi request reprint Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS, Milan, Italy
    J Viral Hepat 15:79-88. 2008
    ..Tolerance to IFN monotherapy was unsatisfactory, particularly to pegylated IFN. The optimal antiviral treatment of chronic hepatitis C in dialysis populations is currently under active investigation...
  30. doi request reprint HBV-related liver disease in renal insufficiency: successful antiviral therapy with entecavir
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 34:1031-5. 2011
    ..Prospective, controlled clinical trials are needed to confirm these encouraging results...
  31. ncbi request reprint Hepatitis B and hepatitis C virus and chronic kidney disease
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    Acta Gastroenterol Belg 73:465-71. 2010
    ..The standard of care for hepatitis C infection in patients on regular dialysis is monotherapy with conventional interferon, according to recent guidelines. Only dire circumstances justify interferon use after renal transplantation...
  32. doi request reprint Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Via Commenda 15, Milan, Italy
    Aliment Pharmacol Ther 33:815-21. 2011
    ..However, the impact of diabetes mellitus on the immune response to HBV vaccine in patients receiving long-term dialysis remains unclear...
  33. doi request reprint Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Pad Croff, Via Commenda 15, 20122, Milan, Italy
    Dig Dis Sci 56:1282-9. 2011
    ..Several studies to clarify the risk factors for incidence of chronic kidney disease among liver transplant recipients, including preoperative kidney function, have yielded conflicting results...
  34. ncbi request reprint Chronic kidney disease after liver transplantation: Recent evidence
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 33:803-11. 2010
    ..The use of mycophenolic acid- or sirolimus-based immunosuppression in calcineurin-inhibitors sparing protocols is an area of intense research...
  35. doi request reprint Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 18:730-7. 2011
    ..It remains unclear whether the higher seroprotection rate achieved with intradermal route translates into a lower frequency of de novo hepatitis B among patients on maintenance dialysis...
  36. ncbi request reprint Therapy with nucleos(t)ide analogues: current role in dialysis patients
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 33:329-38. 2010
    ....
  37. doi request reprint Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients
    F Fabrizi
    Maggiore Hospital, IRCCS Foundation, Milano, Italy
    Aliment Pharmacol Ther 32:756-62. 2010
    ..Some authors have suggested that levamisole improves immune response to HBV vaccine in dialysis population. However, consistent information on this issue does not exist...
  38. doi request reprint Hepatic disorders in chronic kidney disease
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Pad Croff, Via Commenda 15, 20122 Milano, Italy
    Nat Rev Nephrol 6:395-403. 2010
    ....
  39. doi request reprint Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Med Virol 82:768-75. 2010
    ..Tolerance to pegylated-IFN monotherapy was unsatisfactory. Prospective trials are in progress to assess the optimal antiviral therapy for chronic hepatitis C in dialysis patients...
  40. ncbi request reprint Health-related quality of life in dialysis patients with HCV infection
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 32:473-81. 2009
    ..Information on HRQOL indices in patients with HCV on maintenance dialysis is extremely limited but the available evidence shows that HCV infection impairs HRQOL, especially in mental aspects, among patients on maintenance hemodialysis...
  41. ncbi request reprint Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    Int J Artif Organs 32:1-11. 2009
    ..Clinical trials aimed at clarifying this issue are under way...
  42. ncbi request reprint Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Int J Artif Organs 31:675-82. 2008
    ..To examine the association between HCV infection and the occurrence of post-transplant diabetes mellitus (PTDM) among renal transplant patients...
  43. doi request reprint Kinetics of hepatitis B virus load and haemodialysis: a prospective study
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    J Viral Hepat 15:917-21. 2008
    ..This phenomenon could explain the low viral loads in these patients. Prospective studies are in progress to identify the mechanisms responsible for reduction in HBV load during haemodialysis...
  44. ncbi request reprint Hepatitis B virus infection in the dialysis population: current perspectives
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan Italy
    Int J Artif Organs 31:386-94. 2008
    ..No controlled trials for the treatment of hepatitis B with either interferon or lamivudine in dialysis patients are currently available...
  45. ncbi request reprint Transmission of hepatitis C virus infection in hemodialysis: current concepts
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy
    Int J Artif Organs 31:1004-16. 2008
    ..Routine audit precautions (general and for dialysis machines) are recommended on a regular basis within HD units...
  46. ncbi request reprint De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRRCS, 15 Milano, Italy
    Aliment Pharmacol Ther 21:861-9. 2005
    ..It is conceived for screening of donor blood products to significantly reduce the 'serologic window' occurring before seroconversion during acute hepatitis C virus...
  47. ncbi request reprint Transplanting solid organs from HBsAg negative donors positive for antibody to hepatitis B core antigen: the implications
    F Fabrizi
    Division of Nephrology, Dialysis and Transplantation, Institute of Hygiene and Preventive Medicine, Policlinico IRCCS, Milan, Italy
    Int J Artif Organs 26:972-83. 2003
  48. ncbi request reprint Kinetics of hepatitis C virus load during hemodialysis: novel perspectives
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
    J Nephrol 16:467-75. 2003
    ..It is evident that additional long-term longitudinal studies by serial viral load estimations are needed to better define the dynamics of HCV viral load in the dialysis population...
  49. ncbi request reprint Novel perspectives on hepatitis B vaccine in dialysis population
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, Policlinico IRCCS, Milan, Italy
    Int J Artif Organs 25:174-81. 2002
  50. ncbi request reprint Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients
    F Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Aliment Pharmacol Ther 18:1071-81. 2003
    ..The efficacy of interferon monotherapy in dialysis patients with chronic hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue...
  51. ncbi request reprint [Natural history of hepatitis C virus infection in dialysis]
    F Fabrizi
    Divisione di Nefrologia e Dialisi, Istituto di Igiene e Medicina Preventiva, Ospedale Maggiore, IRCCS, Milano Italy
    G Ital Nefrol 20:470-7. 2003
    ..Dialysis patients desperately need effective and safe antiviral agents for the treatment of HCV-related liver disease...
  52. ncbi request reprint HCV-associated renal diseases after liver transplantation
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Int J Artif Organs 26:452-60. 2003
  53. ncbi request reprint Genetic variability of hepatitis C virus in dialysis: the implications
    F Fabrizi
    Division of Nephrology, Dialysis and Renal Transplantation, Maggiore Hospital, Policlinico IRCCS, Milano, Italy
    Int J Artif Organs 25:1034-48. 2002
  54. ncbi request reprint Management of hepatitis B after renal transplantation: an update
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Institute of Hygiene and Preventive Medicine, Ospedale Maggiore Policlinico, IRCCS, Milano, Italy
    J Nephrol 15:113-22. 2002
    ..The combination of newer nucleoside analogues with lamivudine, analogous to HIV, may further improve the efficacy of antiviral therapy against HBV after RT...
  55. ncbi request reprint Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage
    Fabrizio Fabrizio
    Division of Nephrology, Dialysis and Transplantation, Maggiore Hospital, Policlinico IRCCS, Milano, Italy
    J Nephrol 15:605-13. 2002
    ..Prospective long-term studies are in progress to assess the risk of de novo HBV infection (HBsAg seroconversion) in renal transplant recipients who have not been successfully immunized with vaccine against HBV...
  56. ncbi request reprint Hepatitis B virus infection in hemodialysis: recent discoveries
    Fabrizio Fabrizi
    Nephrology and Dialysis Division, Maggiore Hospital, Policlinic IRCCS, Milan, Italy
    J Nephrol 15:463-8. 2002
    ..Continued implementation of the long-recommended infection control procedures against HBV within dialysis units is strongly suggested...
  57. ncbi request reprint Epidemiology of GB virus c/hepatitis g virus infection in patients on peritoneal dialysis
    Fabrizio Fabrizi
    Perit Dial Int 22:405-10. 2002
    ..The epidemiology of GBV-C/HGV infection in patients on peritoneal dialysis is scarce and mostly based on RT-PCR technology...
  58. ncbi request reprint [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study]
    F Fabrizi
    Divisioni di Nefrologia e Dialisi, Ospedale Maggiore, IRCCS, Milano, Italy
    G Ital Nefrol 19:149-54. 2002
    ..The clinical significance related to the presence of HBsAg in serum of dialysis patients has not been completely understood...
  59. ncbi request reprint Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizio Fabrizi
    Division of Nephrology, Dialysis, Transplantation, Maggiore Hospital, IRCCS, Milan, Italy
    J Nephrol 16:617-25. 2003
    ..With appropriate informed consent, use of a renal graft from an HCV positive donor may be offered to an HCV infected recipient. Additional studies are needed to clarify the link between donor HCV-positive kidneys and patient mortality...
  60. ncbi request reprint Influence of hepatitis B virus virema upon serum aminotransferase activity in dialysis population
    F Fabrizi
    Division of Nephrology, Dialysis and Transplantation, Maggiore Hospital, IRCCS, Milano, Italy
    Int J Artif Organs 26:1048-55. 2003
    ..Also, the clinical impact related to the virological characteristics of HBV in dialysis has not been evaluated...
  61. ncbi request reprint Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, 15 Milan, Italy
    Aliment Pharmacol Ther 21:623-32. 2005
    ..Clinical trials are under way to assess if the hepatitis C virus-linked predisposition to new onset diabetes mellitus after renal transplantation may be reduced by newer immunosuppressive medications...
  62. pmc Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS, Via Commenda 15, 20122 Milan, Italy
    J Clin Microbiol 43:414-20. 2005
    ..The present study supports the use of the total anti-HCV core Ag ELISA for assessing viral load among dialysis patients with HCV infection...
  63. ncbi request reprint Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis
    F Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Aliment Pharmacol Ther 20:1271-7. 2004
    ....
  64. ncbi request reprint [Natural history of hepatitis B virus infection in dialysis patients: prospective study by quantitative analysis of HBV viremia]
    F Fabrizi
    Divisione di Nefrologia e Dialisi, Ospedale Maggiore, IRCCS, Milano
    G Ital Nefrol 19:294-300. 2002
    ..Amplicor HBV MonitorTM Test Kit amplifies a sequence in the pre-Core/Core region of the HBV genome with biotinylated and non-biotinylated oligonucleotide primers...
  65. ncbi request reprint Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease
    F Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Aliment Pharmacol Ther 20:1053-62. 2004
    ..Age-associated changes in immune status may contribute to decreased vaccine efficacy in older individuals although contradictory results have been reported in individuals with normal kidney function...
  66. ncbi request reprint Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Transplantation 77:859-64. 2004
    ..Numerous reports have appeared on lamivudine use for the treatment of hepatitis B virus (HBV) infection after renal transplantation (RT). However, the efficacy and safety of lamivudine after RT remain unclear...
  67. ncbi request reprint Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence
    F Fabrizi
    The Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center and UCLA School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
    Minerva Urol Nefrol 56:249-57. 2004
    ..Preliminary reports suggest that lamivudine appears to be safe and effective in patients receiving long-term dialysis...
  68. ncbi request reprint [Natural history of HBV in dialysis population]
    F Fabrizi
    Divisione di Nefrologia e Dialisi, Istituto di Igiene e Medicina Preventiva, Ospedale Maggiore, IRCCS, Milano, Italy
    G Ital Nefrol 21:21-8. 2004
    ..Prospective clinical trials are under way to better define the virological features of HBV in the dialysis population...
  69. ncbi request reprint Peritoneal dialysis and infection by hepatitis B and C virus
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Int J Artif Organs 26:278-88. 2003
  70. ncbi request reprint Serological and molecular testing in hepatitis B and the dialysis patient
    F Fabrizi
    Division of Nephrology and Dialysis, Ospedale Maggiore, Policlinico IRCCS, Milano, Italy
    Int J Artif Organs 25:91-9. 2002
  71. ncbi request reprint Recent advances in the management of hepatitis C in the dialysis population
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy
    Int J Artif Organs 25:503-11. 2002
  72. ncbi request reprint Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin
    D Carriero
    Division of Liver Diseases, Mount Sinai Medical Center and School of Medicine, New York City, USA
    Int J Artif Organs 31:295-302. 2008
    ..No safe and effective therapy exists for chronic hepatitis C in dialysis patients. Available data on the antiviral treatment of hepatitis C in dialysis population is mostly based on standard interferon monotherapy...
  73. ncbi request reprint Hepatitis C infection and the patient with end-stage renal disease
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, Policlinico IRCCS, Milan, Italy
    Hepatology 36:3-10. 2002
    ..Interferon remains contraindicated post-RT because of concern about precipitating graft dysfunction...
  74. ncbi request reprint HBV infection in patients with end-stage renal disease
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center and Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, California 90048, USA
    Semin Liver Dis 24:63-70. 2004
    ..Liver biopsy prior to renal transplantation is crucial in order to identify and exclude patients with advanced fibrosis or even cirrhosis...
  75. ncbi request reprint Hepatitis C infection associated with renal disease and chronic renal failure
    Fred F Poordad
    The Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90048, USA
    Semin Liver Dis 24:69-77. 2004
    ..IFN therapy in renal transplantation patients is not recommended because of potential graft rejection...
  76. ncbi request reprint Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis
    F Fabrizi
    Division of Nephrology and Dialysis, Institute of Hygiene and Preventive Medicine, Maggiore Hospital, Milano, Italy
    Am J Kidney Dis 38:1009-15. 2001
    ..Studies aimed to clarify the pathogenesis of this phenomenon are in progress...
  77. ncbi request reprint Hepatitis C therapy with long term remission after renal transplantation
    S Bunnapradist
    Multi Organ Transplant Program, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Int J Artif Organs 25:1189-93. 2002
    ..We conclude that interferon can offer excellent response in selected dialysis patients with hepatitis C. Alternative strategies with newer antiviral agents are currently under active investigation...
  78. doi request reprint Health care-associated transmission of hepatitis B and C viruses in hemodialysis units
    Fabrizio Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS Foundation, Pad Croff, Via Commenda 15, Milano 20122, Italy
    Clin Liver Dis 14:49-60; viii. 2010
    ..This article summarizes the most recent information on epidemiology, clinical significance, and management of infection by hepatitis B and C viruses in this population...
  79. ncbi request reprint Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milan Italy
    Int J Artif Organs 32:133-40. 2009
    ..Various approaches have been used for hepatorenal syndrome treatment, including vasoconstrictor therapy. Terlipressin, a vasopressin analogue, has frequently been used...
  80. ncbi request reprint Therapy of hepatitis C virus-associated glomerulonephritis: current approaches
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milan Italy
    J Nephrol 21:813-25. 2008
    ....
  81. ncbi request reprint Treatment of chronic viral hepatitis in patients with renal disease
    Fabrizio Fabrizi
    Center for Liver and Kidney Diseases and Transplantation, Cedars Sinai Medical Center, University of California Los Angeles School of Medicine, 8635 West Third Street, Suite 590W, Los Angeles, CA 90048, USA
    Gastroenterol Clin North Am 33:655-70, xi. 2004
    ..This article aims to address the current therapeutic options for patients with renal disease and chronic viral hepatitis...
  82. ncbi request reprint Current status of renal transplantation from HCV-positive donors
    Fabrizio Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milan, Italy
    Int J Artif Organs 32:251-61. 2009
    ..a potential risk related to the use of donor HCV-positive kidneys cannot be excluded, and kidneys from HCV-infected donors should be restricted to recipients with evidence of active viremia at the time of kidney transplantation...
  83. ncbi request reprint Biological dynamics of hepatitis B virus load in dialysis population
    Fabrizio Fabrizi
    Nephrology and Dialysis Division, Institute of Hygiene and Preventive Medicine, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Kidney Dis 41:1278-85. 2003
    ..The aim of this study is to measure monthly HBV viral load (HBV DNA) in a large cohort (n = 29) of hepatitis B surface antigen (HBsAg)-positive chronic dialysis patients during 12 months...
  84. ncbi request reprint Treatment of HCV-related liver diseases after renal transplantation: modern views
    F Fabrizi
    Division of Nephrology, Maggiore Hospital, IRCCS, Milano, Italy
    Int J Artif Organs 26:373-82. 2003
  85. ncbi request reprint Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milan, Italy, and Division of Liver Diseases, Mount Sinai Medical School, New York City, NY, USA
    Int J Artif Organs 30:6-15. 2007
    ..However, scarce information exists on the activity of gamma glutamyltranspeptidase (GGTP) in dialysis patients with infection by hepatotropic viruses...
  86. pmc Automated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosis
    P Martin
    Department of Medicine, School of Medicine, University of California at Los Angeles, 90024 1749, USA
    J Clin Microbiol 36:387-90. 1998
    ..Our data indicate that this novel methodology may be very useful for supplemental anti-HCV testing of specimens repeatedly reactive by ELISA in routine clinical assessments and epidemiologic evaluations...
  87. ncbi request reprint Review article: hepatitis C virus and calcineurin inhibition after renal transplantation
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Aliment Pharmacol Ther 22:657-66. 2005
    ..Prospective, comparative trials of ciclosporin and tacrolimus with large size and adequate follow-up after renal transplantation are in progress...
  88. ncbi request reprint Histopathological features of hepatitis C in renal transplant candidates [see comment]
    P Martin
    Department of Medicine, UCLA School of Medicine, National Genetics Institute, Los Angeles, California, USA
    Transplantation 69:1479-84. 2000
    ..We evaluated the liver biopsy features of chronic HCV in a large population of renal transplant candidates and investigated associations between histopathological changes and host- and virus-related factors...
  89. ncbi request reprint Occult hepatitis B virus infection in dialysis patients: a multicentre survey
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Aliment Pharmacol Ther 21:1341-7. 2005
    ....
  90. ncbi request reprint Hepatitis C virus infection and renal transplantation
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS, Milano, Italy
    Am J Kidney Dis 38:919-34. 2001
    ....
  91. ncbi request reprint Treatment of chronic hepatitis C infection in patients with renal failure
    Paul Martin
    Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA
    Clin Gastroenterol Hepatol 3:S113-7. 2005
    ..In pilot studies, cautious use of reduced doses of ribavirin has been possible in this population with close monitoring of hematocrit levels and additional measures to enhance compensatory erythropoiesis...
  92. ncbi request reprint Epidemiology of hepatitis delta virus (HDV) infection in the dialysis population
    F Fabrizi
    Division of Nephrology and Dialysis, Maggiore Hospital, Policlinico IRCCS, Milano, Italy
    Int J Artif Organs 25:8-17. 2002
  93. ncbi request reprint TT virus infection in end-stage renal disease (ESRD)
    F Fabrizi
    Nephrology and Dialysis Division, University of California at Los Angeles, Los Angeles, California, USA
    J Nephrol 14:80-7. 2001
    ..The possibility that TTV causes pathological changes outside the liver cannot be ruled out. Further studies are in progress to understand the natural history and the epidemiology of TTV infection in patients with ESRD...
  94. doi request reprint Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population
    Vinaya Rao
    Division of Nephrology, School of Medicine, University of Miami, Miami, FL, USA
    Ren Fail 32:721-6. 2010
    ..Accurate detection of HCV viremia (HCV RNA) in dialysis patients requires a sensitive and specific diagnostic test...
  95. ncbi request reprint Kidney and liver involvement in cryoglobulinemia
    Fabrizio Fabrizi
    Divisions of Nephrology and Dialysis, Maggiore Hospital, Milano, Italy
    Semin Nephrol 22:309-18. 2002
    ..Prospective controlled trials are underway on this purpose...
  96. ncbi request reprint GBV-C/HGV infection in end-stage renal disease: a serological and virological survey
    F Fabrizi
    Division of Nephrology and Dialysis, Hospital, Lecco, Italy
    J Nephrol 13:68-74. 2000
    ..In many patients exposed to GBV-C/HGV infection the virus was cleared. The clinical significance of GBV-C/HGV in ESRD remains controversial. Prospective studies with additional serological assays are in progress...
  97. ncbi request reprint GBV-C/HGV infection in end-stage renal disease
    F Fabrizi
    Nephrology and Dialysis Division, Lecco Hospital, Italy
    J Nephrol 12:131-9. 1999
    ....
  98. ncbi request reprint Antiphospholipid (aPL) antibodies in end-stage renal disease
    F Fabrizi
    Nephrology and Dialysis Division, Lecco Hospital, Italy
    J Nephrol 12:89-94. 1999
    ..Further studies are needed to clarify the issue of aPL in ESRD. LA testing should be incorporated into the diagnostic evaluation of recurrent thrombotic episodes in patients on HD...
  99. ncbi request reprint Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients
    F Fabrizi
    Division of Digestive Diseases, UCLA School of Medicine, Los Angeles, Calif, USA
    Am J Nephrol 21:104-11. 2001
    ..The CHIRON RIBA HCV 3.0 Processor System may be very useful for supplemental anti-HCV testing of ELISA repeat reactive specimens in clinical practice within dialysis units...
  100. ncbi request reprint Hepatitis B virus and renal transplantation
    Fabrizio Fabrizi
    Nephron 90:241-51. 2002